AU2001279162A1 - Supplement for type 2 diabetes or lipodystrophy - Google Patents

Supplement for type 2 diabetes or lipodystrophy

Info

Publication number
AU2001279162A1
AU2001279162A1 AU2001279162A AU7916201A AU2001279162A1 AU 2001279162 A1 AU2001279162 A1 AU 2001279162A1 AU 2001279162 A AU2001279162 A AU 2001279162A AU 7916201 A AU7916201 A AU 7916201A AU 2001279162 A1 AU2001279162 A1 AU 2001279162A1
Authority
AU
Australia
Prior art keywords
lipodystrophy
diabetes
supplement
type
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001279162A
Inventor
Stacey J. Bell
Judith Shabert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Advanced Functional Foods International Inc
Original Assignee
Functional Foods Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Functional Foods Inc filed Critical Functional Foods Inc
Publication of AU2001279162A1 publication Critical patent/AU2001279162A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A23L33/22—Comminuted fibrous parts of plants, e.g. bagasse or pulp
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A23L33/11—Plant sterols or derivatives thereof, e.g. phytosterols
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Diabetes (AREA)
  • Inorganic Chemistry (AREA)
  • Pediatric Medicine (AREA)
  • Obesity (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
AU2001279162A 2000-08-08 2001-08-02 Supplement for type 2 diabetes or lipodystrophy Abandoned AU2001279162A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US63424700A 2000-08-08 2000-08-08
US09634247 2000-08-08
US09/664,227 US6365176B1 (en) 2000-08-08 2000-09-18 Nutritional supplement for patients with type 2 diabetes mellitus for lipodystrophy
US09664227 2000-09-18
PCT/US2001/024345 WO2002011564A2 (en) 2000-08-08 2001-08-02 Supplement for type 2 diabetes or lipodystrophy

Publications (1)

Publication Number Publication Date
AU2001279162A1 true AU2001279162A1 (en) 2002-02-18

Family

ID=27092106

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001279162A Abandoned AU2001279162A1 (en) 2000-08-08 2001-08-02 Supplement for type 2 diabetes or lipodystrophy

Country Status (4)

Country Link
US (1) US6365176B1 (en)
EP (1) EP1317190A2 (en)
AU (1) AU2001279162A1 (en)
WO (1) WO2002011564A2 (en)

Families Citing this family (90)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1001793B1 (en) 1997-08-08 2005-09-14 Nutrition 21 Chromium/biotin treatment of type ii diabetes
AUPP494798A0 (en) 1998-07-29 1998-08-20 Pacific Biolink Pty Limited Protective protein formulation
ATE480155T1 (en) * 2000-07-19 2010-09-15 Unitika Ltd PHYSIOLOGICALLY EFFECTIVE FOODS AND COSMETICS CONTAINING SPHINGOGLYCOLIPIDES FROM KONJAC TO IMPROVE THE MOISTURE AND ROUGHNESS OF THE SKIN
WO2002072148A1 (en) * 2001-03-08 2002-09-19 Mitochroma Research, Inc Compositions and methods for non-insulin glucose uptake
US20030080191A1 (en) * 2001-10-26 2003-05-01 Allen Lubow Method and apparatus for applying bar code information to products during production
US20050131733A1 (en) * 2001-12-17 2005-06-16 Allen Lubow Sealable individual bar coded packets
EP1466297A4 (en) * 2001-12-17 2005-10-19 Int Barcode Corp Double-sided bar code doubling as a single bar code
ITMI20020731A1 (en) * 2002-04-08 2003-10-08 Ibsa Inst Biochimique Sa PHARMACEUTICAL COMPOSITIONS FOR ACETYLSALICYLIC ACID AND OMEGA-3 OILS
US20040013708A1 (en) * 2002-04-10 2004-01-22 Goulson Melanie J. Aqueous dispersible steryl ester compositions
US6974592B2 (en) * 2002-04-11 2005-12-13 Ocean Nutrition Canada Limited Encapsulated agglomeration of microcapsules and method for the preparation thereof
US7074440B2 (en) * 2002-05-01 2006-07-11 Rulin Xiu Compositions and methods for body weight loss
BR0313186A (en) * 2002-07-23 2005-06-21 Nutrinova Gmbh Cholesterol lowering agent from dietary fiber and cholesterol lowering substances
US8821915B2 (en) 2002-08-09 2014-09-02 Veroscience, Llc Therapeutic process for the treatment of the metabolic syndrome and associated metabolic disorders
US20040081678A1 (en) * 2002-08-09 2004-04-29 Anthony Cincotta Therapeutic process for the treatment of obesity and associated metabolic disorders
AU2003256104A1 (en) * 2002-08-14 2004-03-03 Bionutrigen Co., Ltd Powder or extracts of plant leaves with anti-obesity effects and anti-obesity food comprising them
SE526943C2 (en) * 2002-08-26 2005-11-22 Indevex Ab food composition
AU2003268235A1 (en) * 2002-09-09 2004-03-29 Mitochroma Research, Inc. Compositions and methods for treating niddm and other conditions and disorders associated with ampk regulation
US20040052915A1 (en) * 2002-09-13 2004-03-18 Carlson Ting L. Use of low glycemic index sweeteners in food and beverage compositions
US6706697B1 (en) * 2002-09-19 2004-03-16 Jason Pharmaceuticals, Inc. Diabetic nutrition and weight loss drink compositions
NZ539625A (en) 2002-09-27 2007-11-30 Martek Biosciences Corp Improved glycemic control for Prediabetes and/or Diabetes Type II Using Docosahexaenoic Acid
CA2499501A1 (en) 2002-09-27 2004-04-08 Martek Biosciences Corporation Prophylactic docosahexaenoic acid therapy for patients with subclinical inflammation
DK1575561T3 (en) * 2002-11-04 2010-09-20 Ocean Nutrition Canada Ltd Multi-capsule microcapsule and method of making them
DK175877B1 (en) * 2002-11-11 2005-05-09 Pharmalett As Preparations for use as a therapeutic agent
US8093292B2 (en) * 2002-11-22 2012-01-10 Bionexus, Ltd. Methods for the treatment of HIV-1 related fat maldistribution, fasting hyperlipidemia and modification of adipocyte physiology
US20060062827A1 (en) * 2002-12-20 2006-03-23 Gel Dynamics, Llc Nutritional supplement composition and method
US20050112177A1 (en) * 2002-12-20 2005-05-26 Dopson Minter H. Nutritional supplement composition and method
US20050112176A1 (en) * 2002-12-20 2005-05-26 Dopson Minter H. Nutritional supplement composition and method
WO2004082559A2 (en) * 2003-03-14 2004-09-30 Doc's Guide, Inc. Unit dosage of liquid omega-3 dietary supplement in dosage package
CA2527737A1 (en) * 2003-05-31 2004-12-09 Forbes Medi-Tech Inc. Composition comprising one or more phytosterols and/or phytostanols and glucomannan and uses of the composition in treating lipid disorders in individuals with and without type iidiabetes
BRPI0412189A (en) * 2003-06-30 2006-08-22 Nestec Sa composition for treating and / or preventing type 2 diabetes mellitus dysfunction
US7875291B1 (en) 2003-09-05 2011-01-25 Glu-Pro, Inc. Composition for managing diabetes, obesity, and hyperlipidemia and associated methods
US7332181B1 (en) * 2003-09-05 2008-02-19 Glu-Pro, Inc. Composition for managing diabetes, obesity, and hyperlipidemia and associated methods
WO2005070442A1 (en) * 2003-12-22 2005-08-04 Council Of Scientific & Industrial Research A synergistic composition for treating hyperlipidemia
US20050147620A1 (en) * 2004-01-05 2005-07-07 Karl Bozicevic Cinnamon formulation for reducing cholesterol and/or glucose levels
US7172773B2 (en) * 2004-04-26 2007-02-06 Renew Life Inc. Food supplement formulation
EP1652512A1 (en) * 2004-11-02 2006-05-03 Medesis Pharma Reverse micelle composition for delivery of metal cations comprising a diglyceride and a phytosterol and method of preparation
EP1656934A1 (en) * 2004-11-12 2006-05-17 Cognis IP Management GmbH Use of physiologically active fatty acids for treating lipodystrophy
US7297686B2 (en) * 2004-11-16 2007-11-20 Hwang David L Chromium complex with insulin-like activity
US20060136307A1 (en) * 2004-11-24 2006-06-22 Hays James J Publication system
US8034450B2 (en) * 2005-01-21 2011-10-11 Ocean Nutrition Canada Limited Microcapsules and emulsions containing low bloom gelatin and methods of making and using thereof
WO2006109194A2 (en) * 2005-01-27 2006-10-19 Ocean Nutrition Canada Ltd. Chromium-fatty acid compounds and methods of making and using thereof
CA2596023A1 (en) * 2005-01-27 2006-11-09 Ocean Nutrition Canada Ltd. Fatty acid-benzenediol derivatives and methods of making and using thereof
ES2444847T3 (en) * 2005-02-15 2014-02-27 Cargill, Incorporated Syrup Preparation Procedures
CN101184780B (en) 2005-05-05 2012-10-03 森馨香料公司 Production of beta-glucans and mannans
US9968120B2 (en) * 2006-05-17 2018-05-15 Dsm Nutritional Products Ag Homogenized formulations containing microcapsules and methods of making and using thereof
US8202546B2 (en) * 2005-08-04 2012-06-19 Vertical Pharmaceuticals, Inc. Nutritional supplement for use under physiologically stressful conditions
US7998500B2 (en) * 2005-08-04 2011-08-16 Vertical Pharmaceuticals, Inc. Nutritional supplement for women
US7901710B2 (en) * 2005-08-04 2011-03-08 Vertical Pharmaceuticals, Inc. Nutritional supplement for use under physiologically stressful conditions
US8263137B2 (en) * 2005-08-04 2012-09-11 Vertical Pharmaceuticals, Inc. Nutritional supplement for women
WO2007041470A2 (en) * 2005-09-30 2007-04-12 Archer-Daniels-Midland Company High-protein soy-wheat crisps
WO2007075841A1 (en) * 2005-12-20 2007-07-05 Cenestra, Llc Omega 3 fatty acid formulations
KR20090029699A (en) * 2006-04-07 2009-03-23 오션 뉴트리션 캐나다 리미티드 Emulsions and microcapsules with substances having low interfacial tension, methods of making and using thereof
ES2391305T3 (en) 2006-04-12 2012-11-23 Unilever N.V. Oral composition comprising a polyunsaturated fatty acid and salicylic acid to obtain an anti-inflammatory effect on the skin
KR20170042364A (en) * 2006-06-05 2017-04-18 디에스엠 뉴트리셔널 프라덕츠 아게 Microcapsules with improved shells
US20080118441A1 (en) * 2006-11-19 2008-05-22 Washington Joseph A Compositions and methods for the treatment of gastrointestinal conditions
US20100130611A1 (en) * 2006-12-20 2010-05-27 Cenestra Llc Omega 3 fatty acid formulations
CA2675123C (en) 2007-01-10 2017-04-11 Ocean Nutrition Canada Limited Vegetarian microcapsules
ES2841379T3 (en) 2007-03-13 2021-07-08 Jds Therapeutics Llc Procedures and compositions for the sustained release of chromium
US20080305095A1 (en) * 2007-06-05 2008-12-11 Mitchell Karl Nutritional Drink
US8613963B2 (en) * 2007-06-05 2013-12-24 Healthy Drink Discoveries Incorporated Nutritional supplement
US20100021572A1 (en) * 2007-06-05 2010-01-28 Mitchell Karl Nutritional Drink
WO2009002867A2 (en) 2007-06-26 2008-12-31 Nutrition 21, Inc. Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement
ITMI20080219A1 (en) * 2008-02-13 2009-08-14 Bruna Maria Bossi FOOD PREPARATION WITH GINSENG TASTE
CN103251631A (en) * 2008-05-13 2013-08-21 根梅迪卡治疗公司 Salicylate conjugates useful for treating metabolic disorders
CA2676518A1 (en) * 2008-08-29 2010-02-28 Kraft Foods Global Brands Llc Whey protein pre-load
BRPI1013878A2 (en) * 2009-03-16 2016-04-05 Genmedica Therapeutics Sl method for treating metabolic disorders, and, compound
WO2010106083A1 (en) * 2009-03-16 2010-09-23 Genmedica Therapeutics Sl Combination therapies for treating metabolic disorders
US9352025B2 (en) 2009-06-05 2016-05-31 Veroscience Llc Combination of dopamine agonists plus first phase insulin secretagogues for the treatment of metabolic disorders
WO2011028618A1 (en) * 2009-08-26 2011-03-10 Kameron Jay Carlson Composition and method for reducing blood glucose levels
HUP1000357A2 (en) * 2010-07-08 2012-10-29 Hyd Kutato Fejlesztoe Kft Pharmaceutical and food products suitable for activating of glucose-transporters
US8889157B1 (en) 2010-08-31 2014-11-18 Gary L'Europa Composition for cardiovascular treatment
US8466197B2 (en) 2010-12-14 2013-06-18 Genmedica Therapeutics Sl Thiocarbonates as anti-inflammatory and antioxidant compounds useful for treating metabolic disorders
KR101836957B1 (en) 2011-03-01 2018-03-09 제이디에스 테라퓨틱스, 엘엘씨 Compositions of insulin and chromium for the treatment and prevention of diabetes, hypoglycemia and related disorders
ES2395529B1 (en) 2011-06-08 2014-04-11 Pri, S.A. SYNERGIC COMBINATION FOR THE TREATMENT OF MELLITUS DIABETES TYPE 2.
BR112014003545A8 (en) * 2011-08-16 2017-06-20 Abbott Lab method to turn a meal
AU2013204801B2 (en) 2012-05-23 2014-11-06 Omniblend Innovation Pty Ltd Composition and method for management of diabetes or pre-diabetes
US9897565B1 (en) 2012-09-11 2018-02-20 Aseko, Inc. System and method for optimizing insulin dosages for diabetic subjects
US9171343B1 (en) 2012-09-11 2015-10-27 Aseko, Inc. Means and method for improved glycemic control for diabetic patients
US9486580B2 (en) 2014-01-31 2016-11-08 Aseko, Inc. Insulin management
US9233204B2 (en) 2014-01-31 2016-01-12 Aseko, Inc. Insulin management
CA2949369C (en) * 2014-06-11 2023-06-13 Poviva Tea, Llc Food and beverage compositions infused with lipophilic active agents and methods of use thereof
US11081226B2 (en) 2014-10-27 2021-08-03 Aseko, Inc. Method and controller for administering recommended insulin dosages to a patient
WO2016069475A1 (en) 2014-10-27 2016-05-06 Aseko, Inc. Subcutaneous outpatient management
US20180055074A1 (en) * 2015-02-04 2018-03-01 Natalja Klein Super food beverage
US20160219921A1 (en) * 2015-02-04 2016-08-04 Natalja Klein Super food beverage
WO2016171571A1 (en) * 2015-04-21 2016-10-27 Ajw Enterprises Limited Compositions and kits for the treatment and prevention of blood glucose disorders
US9886556B2 (en) 2015-08-20 2018-02-06 Aseko, Inc. Diabetes management therapy advisor
MX2018009748A (en) 2016-02-11 2019-02-07 Nutrition 21 Llc Chromium containing compositions for improving health and fitness.
WO2020016811A1 (en) * 2018-07-20 2020-01-23 Nutraceutical Holdings Inc. Compositions, uses and methods for treatment and/or prevention of elevated cholesterol, hypercholesterolemia, and cardiovascular disease
CA3172889A1 (en) 2020-04-20 2021-10-28 John Docherty Compositions and methods for enhanced delivery of antiviral agents

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5104676A (en) * 1991-06-27 1992-04-14 Abbott Laboratories Weight control product
US5480657A (en) * 1993-10-27 1996-01-02 Allen; Ann De Wees T. Composition comprising caffeine chromium and fructose for weight control and use thereof
CN1123113A (en) * 1994-11-18 1996-05-29 郭湘泗 Super-concentrated nutrition with special effect for reducing weight
BR9915693A (en) * 1998-11-25 2001-08-14 Nutri Pharma As Composition comprising soy protein, dietary fiber and a phytoestrogen compound and its use in the prevention and / or treatment of type 2 diabetes, the metabolic syndrome and associated cardiovascular diseases

Also Published As

Publication number Publication date
WO2002011564A2 (en) 2002-02-14
EP1317190A2 (en) 2003-06-11
US6365176B1 (en) 2002-04-02
WO2002011564A3 (en) 2002-05-02

Similar Documents

Publication Publication Date Title
AU2001279162A1 (en) Supplement for type 2 diabetes or lipodystrophy
AU4911199A (en) Cosmetic composition
AU3160001A (en) Bleaching composition
AU2069099A (en) Sensor
EP1144570A3 (en) Effervescence components
AU4318000A (en) Agarobiose-containing composition
AU5554099A (en) Motion sensor
AU7683700A (en) Co sensor
AU4378799A (en) Dietary supplement
AU5036299A (en) Thermosorption sensor
AU2176001A (en) Cosmetic composition
AU3000599A (en) Moisturizing compositions
AU5107400A (en) Heat-evolving cosmetics
AU6277699A (en) Guarantee 20
AU4215599A (en) Dermatological compounds
AU1394201A (en) Sunscreen
AU6310600A (en) Composition
AU5567600A (en) Hairdye composition
AUPQ009199A0 (en) Wetsuit
AU1415800A (en) Cosmetics
AU6610500A (en) Antidiscoloration composition
AU2648899A (en) Composition
AU1539901A (en) Composition
AU2001273594A1 (en) Dimeric streptavidins
AU4636099A (en) Cosmetic composition